Company filings profile · CIK 0001719406
NRX Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for NRX Pharmaceuticals, Inc. (NRXP): 7 filings in the last 90 days vs 7 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 6, 2026. Source-linked, daily-refreshed.
Material 8-K events — NRX Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 5, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Sep 16, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 14, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 17, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 7, 2026 | Regulation FD Disclosure | ↗ |
| Jul 22, 2026 | Other Events | ↗ |
| Jun 4, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Mar 24, 2026 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 2, 2026 | Departure/Election of Directors or Officers | ↗ |
| Jan 16, 2026 | Delisting / Listing-Rule Failure; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Nov 26, 2025 | Change in Auditor; Financial Statements and Exhibits | ↗ |
Watch NRX Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 5, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Sep 16, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 14, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 17, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 10-Q | FORM 10-Q | ↗ |
| Aug 7, 2026 | 8-K | Regulation FD Disclosure | ↗ |
| Jul 22, 2026 | 8-K | Other Events | ↗ |
| Jun 4, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 3, 2026 | 424B5 | FORM 424B5 | ↗ |
| Jun 2, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | 424B5 | FORM 424B5 | ↗ |
| May 22, 2026 | 25-NSE | ↗ | |
| May 15, 2026 | 10-Q | FORM 10-Q | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| Mar 24, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Mar 23, 2026 | 10-K | FORM 10-K | ↗ |
| Feb 24, 2026 | DEFA14A | FORM DEFA14A | ↗ |
| Feb 23, 2026 | ARS | ARS | ↗ |
| Feb 23, 2026 | DEF 14A | FORM DEF 14A | ↗ |
| Feb 17, 2026 | 4 | FORM 4 | ↗ |
| Feb 17, 2026 | 3 | FORM 3 | ↗ |
| Feb 17, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Feb 17, 2026 | 424B5 | FORM 424B5 | ↗ |
| Feb 13, 2026 | PRE 14A | FORM PRE 14A | ↗ |
| Feb 2, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Jan 16, 2026 | 8-K | Delisting / Listing-Rule Failure; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Dec 29, 2025 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 22, 2025 | EFFECT | Item ; Item ; Item | ↗ |
| Dec 22, 2025 | 424B3 | FORM 424B3 | ↗ |
| Dec 18, 2025 | CORRESP | ↗ | |
| Dec 12, 2025 | S-3/A | FORM S-3/A | ↗ |
| Nov 26, 2025 | 8-K | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Nov 21, 2025 | 8-K/A | Financial Statements and Exhibits | ↗ |
| Nov 14, 2025 | 10-Q | FORM 10-Q | ↗ |
| Oct 23, 2025 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 26, 2025 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 12, 2025 | 8-K | Completion of Acquisition/Disposition; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 10, 2025 | 4 | ↗ | |
| Sep 10, 2025 | 4 | ↗ |